← All stocks

GeneDx Holdings Corp.

WGS Net buying
CIK 0001818331 #1896 in the set updated 17 Sep 2026
Bought (12 mo)
$106.60M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$22.53M
$1.90M on a plan · $11.68M straight out of an exercise
Sold at will
$8.94M
26 of 113 sales
Net
+$84.07M
+$97.66M against sales at will

By person

11 insiders · 147 transactions
12.6×

Katherine Stueland holds 12.6 times base salary in stock. $9.03M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $84.22, the price Class A Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Meister Keith A.
Director
$74.03M (29)
+$74.03M
4,808,275
16.12%
$404.94M
+93.8%
Casdin Capital, LLC entity
Director
$32.57M (5)
+$32.57M
3,707,164
12.43%
$312.21M
+5.7%
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$11.87M (42) scheduled
−$11.87M
107,227
0.3596%
$9.03M
+3.4%
RUCH JOSHUA
Director
$6.09M (15)
−$6.09M
153,382
0.5143%
$12.92M
−7.6%
Feeley Kevin
CHIEF FINANCIAL OFFICER
$3.71M (44) scheduled
−$3.71M
41,476
0.1391%
$3.49M
−53.7%
Dechairo Bryan
Chief Operating Officer
$850.56K (12) scheduled
−$850.56K
0
0.0000%
$0.00
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
10% owner
2,719,692
9.12%
$229.05M
−27.1%
Ryan Jason
Director
118,764
0.3982%
$10.00M
−64.0%
PFENNIGER RICHARD C JR
Director
45,082
0.1512%
$3.80M
+63.0%
Leproust Emily M.
Director
24,852
0.0833%
$2.09M
+197.6%
Casdin Eli
Director
24,093
0.0808%
$2.03M
+217.3%
Insider
Date
Role
Action
Shares
Price
Amount
Stueland Katherine
4 Mar 2026
CHIEF EXECUTIVE OFFICER
Sell
9,133
$79.25
$723.78K
Stueland Katherine
4 Mar 2026
CHIEF EXECUTIVE OFFICER
Sell
10,465
$78.61
$822.62K
Stueland Katherine
4 Mar 2026
CHIEF EXECUTIVE OFFICER
Sell
5,861
$77.63
$454.97K
Feeley Kevin
4 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
2,220
$79.25
$175.93K
Feeley Kevin
4 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
2,543
$78.61
$199.90K
Feeley Kevin
4 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
1,424
$77.63
$110.54K
Feeley Kevin
2 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
287
$77.52
$22.25K
Dechairo Bryan
2 Feb 2026
Chief Operating Officer
Sell
1,166
$100.31
$116.97K
Dechairo Bryan
2 Feb 2026
Chief Operating Officer
Sell
1,662
$99.40
$165.20K
Dechairo Bryan
2 Feb 2026
Chief Operating Officer
Sell
492
$98.61
$48.52K
Dechairo Bryan
2 Feb 2026
Chief Operating Officer
Sell
93
$96.77
$9.00K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
728
$162.04
$117.96K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
11,234
$161.16
$1.81M
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
8,944
$160.45
$1.44M
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
6,279
$159.28
$1.00M
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
2,016
$158.40
$319.34K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
147
$162.04
$23.82K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
2,268
$161.16
$365.50K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
1,805
$160.45
$289.61K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
1,268
$159.28
$201.96K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
407
$158.40
$64.47K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
72
$162.04
$11.67K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
1,117
$161.16
$180.01K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
889
$160.45
$142.64K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
625
$159.28
$99.55K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
201
$158.40
$31.84K

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 71
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 343,025
History held since 26 Jul 2021